Kenzie L. Preston mostly deals with Anesthesia, Methadone, Placebo, Pharmacology and Psychiatry. The Anesthesia study combines topics in areas such as Agonist, Buprenorphine, Opioid and Narcotic antagonist. Her Buprenorphine research focuses on Partial agonist and how it relates to Sedation.
In her research, Opiate is intimately related to Heroin, which falls under the overarching field of Methadone. The concepts of her Placebo study are interwoven with issues in Oral administration, Morphine, Physical dependence, Cannabinoid and Volunteer. Her work deals with themes such as Antagonist and Blood pressure, Heart rate, which intersect with Pharmacology.
Her main research concerns Anesthesia, Methadone, Opioid, Psychiatry and Pharmacology. Her biological study spans a wide range of topics, including Agonist, Hydromorphone, Buprenorphine, Placebo and Substance abuse. Her Methadone research is multidisciplinary, incorporating elements of Internal medicine, Contingency management, Heroin and Opiate.
Kenzie L. Preston combines subjects such as Analgesic, Sedation and Partial agonist with her study of Opioid. Her Psychiatry research is multidisciplinary, relying on both Young adult, Clinical trial and Clinical psychology. Her Pharmacology research integrates issues from Antagonist, Agonist-antagonist and Dopamine.
Kenzie L. Preston mainly investigates Craving, Psychiatry, Clinical psychology, Methadone and Opioid use disorder. Kenzie L. Preston interconnects Ecology, Heroin, Mood, Placebo and Abstinence in the investigation of issues within Craving. Her Placebo study frequently involves adjacent topics like Anesthesia.
In general Psychiatry, her work in Drug and Addiction is often linked to Context, Injury prevention and Human factors and ergonomics linking many areas of study. Kenzie L. Preston studies Methadone maintenance which is a part of Methadone. Her work carried out in the field of Opioid use disorder brings together such families of science as Buprenorphine and Chronic pain.
Kenzie L. Preston focuses on Craving, Psychiatry, Clinical psychology, Heroin and Mood. Kenzie L. Preston has researched Craving in several fields, including Intervention and Placebo. Her Placebo study integrates concerns from other disciplines, such as Ingestion, Ecology, Abstinence and Opioid.
Her Clinical psychology research is multidisciplinary, incorporating perspectives in Methadone, Drug craving, Opioid dependent and Cue induced craving. Her biological study spans a wide range of topics, including Young adult, Buprenorphine, Clinical trial and Cannabis. Her studies in Clinical trial integrate themes in fields like Psychosocial, Amphetamine-Related Disorders and Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
S. L. Walsh;K. L. Preston;M. L. Stitzer;E. J. Cone.
Clinical Pharmacology & Therapeutics (1994)
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.
David H. Epstein;David H. Epstein;Kenzie L. Preston;Jane Stewart;Yavin Shaham.
Psychopharmacology (2006)
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
Marilyn A. Huestis;David A. Gorelick;Stephen J. Heishman;Kenzie L. Preston.
Archives of General Psychiatry (2001)
Sustained Cocaine Abstinence in Methadone Maintenance Patients Through Voucher-Based Reinforcement Therapy
Kenneth Silverman;Stephen T. Higgins;Robert K. Brooner;Ivan D. Montoya;Ivan D. Montoya.
Archives of General Psychiatry (1996)
Acute administration of buprenorphine in humans: Partial agonist and blockade effects
S. L. Walsh;Kenzie L. Preston;G. E. Bigelow;M. L. Stitzer.
Journal of Pharmacology and Experimental Therapeutics (1995)
The reinforcing and subjective effects of morphine in post-addicts: a dose-response study.
Richard J Lamb;K. L. Preston;C. W. Schindler;R. A. Meisch.
Journal of Pharmacology and Experimental Therapeutics (1991)
Real-time electronic-diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use
David H. Epstein;Jessica Willner-Reid;Massoud Vahabzadeh;Mustapha Mezghanni.
Archives of General Psychiatry (2009)
Abuse potential and pharmacological comparison of tramadol and morphine
Kenzie L. Preston;Donald R. Jasinski;Margaret Testa.
Drug and Alcohol Dependence (1991)
Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
Kenneth Silverman;Conrad J. Wong;Annie Umbricht-Schneiter;Ivan D. Montoya;Ivan D. Montoya.
Journal of Consulting and Clinical Psychology (1998)
Low-dose caffeine physical dependence in humans.
R R Griffiths;S M Evans;S J Heishman;K L Preston.
Journal of Pharmacology and Experimental Therapeutics (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institute on Drug Abuse
Johns Hopkins University School of Medicine
Johns Hopkins University
Johns Hopkins University School of Medicine
National Institute on Drug Abuse
Johns Hopkins University School of Medicine
Johns Hopkins University School of Medicine
University of Memphis
Virginia Tech
University of Vermont
ETH Zurich
Middle East Technical University
University of La Laguna
University of Pittsburgh
University of Northern British Columbia
University of Sydney
The University of Texas MD Anderson Cancer Center
Pennsylvania State University
Imperial College London
Wayne State University
Humboldt-Universität zu Berlin
University of Michigan–Ann Arbor
Vrije Universiteit Amsterdam
University of Miami
University of Melbourne
University of Nottingham